Discover 200 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 200
Prostate Artery Embolization: Single Center Experience
for
Benign Prostatic Hyperplasia (BPH),
Location: Jackson MS
Sponsor: University of Mississippi Medical Center
Sex: Male
Age: 45+
Code: NCT04766268
Recruiting
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Jackson MS, Memphis TN, Houston TX, San Antonio TX,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04916210
Recruiting
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
for
Sepsis, Acute Infection, Organ Failure
Location: Jackson MS, Iowa City IA, Burnsville MN, Edina MN,
Sponsor: University of Minnesota
Sex: All
Age: 65+
Code: NCT05758246
Phase 2, Recruiting
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
for
Neurodevelopmental Abnormality
Location: Jackson MS, Birmingham AL, Saint Louis MO,
Sponsor: Sharp HealthCare
Sex: All
Age: 1 - 3
Code: NCT03476980
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
for
Prostate Cancer
Location: Jackson MS, Tuscaloosa AL, Memphis TN, Atlanta GA,
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 21+
Code: NCT03151629
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Pilot Study of a Remote ADHD Monitoring Program
for
Attention-deficit/Hyperactivity Disorder, ADHD
Location: Jackson MS, Charleston SC
Sponsor: IDeA States Pediatric Clinical Trials Network
Sex: All
Age: 5 - 11
Code: NCT06743425
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Jackson MS, New Orleans LA, Mobile AL, Memphis TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: Jackson MS, Little Rock AR, Columbus GA, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase 3, Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
for
Endometrial Cancer, Cervical Cancer,
Location: Jackson MS, New Orleans LA, Atlanta GA, Houston TX,
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT05051722
Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Jackson MS, Longview TX, Houston TX, Westwood KS,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06596473
Phase 1, Recruiting
Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
Location: Jackson MS, Durham NC, Rochester MN, Los Angeles CA,
Sponsor: University of California, San Francisco
Sex: Female
Age: 21 - 53
Code: NCT06143631
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Jackson MS, Mobile AL, Shreveport LA, Tyler TX,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Jackson MS, Mobile AL, Little Rock AR, Birmingham AL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Jackson MS, New Orleans LA, Memphis TN, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Jackson MS, New Orleans LA, Germantown TN,